Product Information
NALOXONE HCL 4 MG NASAL SPRAY is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $34.2700 per EA under NDC 00093216568. Its NADAC has been published 200 times since Mar 23, 2022.
FDA first approved this application on Apr 19, 2019.
Strength
4 mg/.1mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093216568
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
1/22/2025
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209522FDA Approved
4/19/2019
On Market Since
12/22/2021
Pharmacological Classes
Price Statistics
The NADAC for NALOXONE HCL 4 MG NASAL SPRAY has been published 200 times since Mar 23, 2022, and over the history we have for it it has declined 21.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $34.2700 per EA |
|---|---|
| All-time high | $44.8261 (Sep 14, 2022) |
| All-time low | $23.7045 (Jul 17, 2024) |
| 52-week high | $34.2700 |
| 52-week low | $34.2700 |
| Median price | $37.7521 |
| Average price | $37.1376 |
| Largest weekly change | +48.6% (Aug 21, 2024) |
| Weeks tracked | 200 |
| Tracking since | Mar 23, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
-9.5%
5Y
N/A
All
-21.8%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naloxone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NALOXONE HCL 4 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for NALOXONE HCL 4 MG NASAL SPRAY, manufactured by Teva Pharmaceuticals USA Inc., is $34.2700 per EA (NDC 00093216568), effective Jan 14, 2026.
How has the price of NALOXONE HCL 4 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for NALOXONE HCL 4 MG NASAL SPRAY has declined 21.8%. It has been tracked across 200 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for NALOXONE HCL 4 MG NASAL SPRAY?
Since Mar 23, 2022, the NADAC for NALOXONE HCL 4 MG NASAL SPRAY has ranged from a low of $23.7045 (Jul 17, 2024) to a high of $44.8261 (Sep 14, 2022), with a median of $37.7521 per EA.
Are there cheaper alternatives to NALOXONE HCL 4 MG NASAL SPRAY?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NALOXONE HCL 4 MG NASAL SPRAY, is $17.1773 per EA — about 50% below NALOXONE HCL 4 MG NASAL SPRAY.
Who manufactures NALOXONE HCL 4 MG NASAL SPRAY?
NALOXONE HCL 4 MG NASAL SPRAY (NDC 00093216568) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.